Compound Information
CJC-1295 No DAC + Ipamorelin
GHRH / Growth Hormone Secretagogue Blend
Available Research Quantities
5 mg + 5 mg
Compound Class
GHRH analog + ghrelin receptor agonist
Research Focus
Growth hormone signaling · Secretory patterns · IGF-1 pathways
Mechanism
Combines signaling through the GHRH receptor with activation of the ghrelin receptor to investigate complementary pathways regulating growth hormone release.
Research Status
Investigational research compounds; not FDA-approved.
Form
Lyophilized powder
Research Use Only. This compound is provided solely for laboratory research purposes and is not intended for human or veterinary use, diagnostic procedures, therapeutic applications, or consumption.